Vir Biotechnology Inc (VIR)

Schlusskurs vom Vortag:

$8.37

Offen:

$8.36

24-Stunden-Volumen:

1.04M

Marktkapitalisierung:

$1.15B

Einnahmen:

$39.49M

Nettoeinkommen (Verlust:

$-615.06M

KGV:

-1.8842

EPS:

-4.49

Netto-Cashflow:

$-800.36M

1W Leistung:

+4.06%

1M Leistung:

-16.49%

6M Leistung:

+6.68%

1J Leistung:

-66.36%

1-Tages-Spanne:

$8.20

$8.4855

52-Wochen-Spanne:

$7.61

$27.48

Vir Biotechnology Inc Stock (VIR) Company Profile

Firmenname

Vir Biotechnology Inc

Sektor

Healthcare (1191)

Branche

Biotechnology (682)

Telefon

415-906-4324

Adresse

499 Illinois Street, Suite 500, San Francisco, CA

Mitarbeiter

237

Twitter

@Vir_Biotech

Nächster Verdiensttermin

2024-05-02

Neueste SEC-Einreichungen

VIR's Discussions on Twitter

Vir Biotechnology Inc Stock (VIR) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-01-29	Herabstufung	JP Morgan	Overweight → Neutral
2023-09-08	Herabstufung	BofA Securities	Buy → Neutral
2023-03-06	Hochstufung	JP Morgan	Neutral → Overweight
2023-02-21	Hochstufung	Goldman	Neutral → Buy
2023-01-27	Hochstufung	Morgan Stanley	Underweight → Equal-Weight
2022-09-14	Eingeleitet	SVB Leerink	Outperform
2022-09-09	Eingeleitet	Morgan Stanley	Underweight
2022-03-03	Hochstufung	Robert W. Baird	Underperform → Neutral
2021-12-21	Herabstufung	Robert W. Baird	Neutral → Underperform
2021-10-25	Hochstufung	JP Morgan	Underweight → Neutral
2021-09-22	Herabstufung	Goldman	Buy → Neutral
2021-06-04	Fortgesetzt	Robert W. Baird	Neutral
2021-01-27	Herabstufung	JP Morgan	Neutral → Underweight
2021-01-20	Bestätigt	H.C. Wainwright	Buy
2020-10-05	Eingeleitet	BofA Securities	Buy
2020-09-14	Hochstufung	Goldman	Neutral → Buy
2020-09-11	Hochstufung	JP Morgan	Underweight → Neutral
2020-08-20	Eingeleitet	Needham	Buy
2020-03-19	Herabstufung	JP Morgan	Neutral → Underweight
2020-03-13	Herabstufung	Goldman	Buy → Neutral
2020-02-27	Herabstufung	Robert W. Baird	Neutral → Underperform
2020-02-04	Herabstufung	JP Morgan	Overweight → Neutral
2019-11-14	Eingeleitet	Robert W. Baird	Neutral
2019-11-05	Eingeleitet	Barclays	Overweight
2019-11-05	Eingeleitet	Cowen	Outperform
2019-11-05	Eingeleitet	Goldman	Buy
2019-11-05	Eingeleitet	JP Morgan	Overweight

Alle ansehen

Vir Biotechnology Inc Aktie (VIR) Neueste Nachrichten

What Makes Vir Biotechnology (VIR) a New Buy Stock

Zacks Investment Research

Assessing Vir Biotechnology: Insights From 5 Financial Analysts

Benzinga

Why MercadoLibre Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Benzinga

Carvana Posts Q4 Results, Joins LegalZoom.com, Comfort Systems And Other Big Stocks Moving Higher On Friday

Benzinga

Wall Street Analysts Believe Vir Biotechnology, Inc. (VIR) Could Rally 186.41%: Here's is How to Trade

Zacks Investment Research

Vir Biotechnology, Inc. (VIR) Reports Q4 Loss, Tops Revenue Estimates

Zacks Investment Research

Finanzdaten der Vir Biotechnology Inc-Aktie (VIR)

Vir Biotechnology Inc (VIR) Umsatz 2024

Vir Biotechnology Inc (VIR) Nettogewinn 2024

Vir Biotechnology Inc (VIR) Free Cashflow 2024

Vir Biotechnology Inc (VIR) Gewinn je Aktie 2024